GenFleet Therapeutics (Shanghai) Inc. will be added as a constituent to several indices, including the Hang Seng Composite Index, Hang Seng Stock Connect Hong Kong Index, Hang Seng Innovative Drug Index, and the MSCI Global Small Cap Index. The additions follow the latest quarterly review results and reflect investors' recognition of the company's sustained value and potential.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics (Shanghai) Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260213-12025326), on February 13, 2026, and is solely responsible for the information contained therein.